News

Are you a graduate or undergraduate student who is preparing for an upcoming research poster presentation? Have you been asked to ... How to talk about your poster in less than 5-minutes Best ...
Students gave 69 poster presentations and 24 oral presentations at the University of North Georgia's (UNG) 30th Annual Research Conference (ARC), held March 21 in the Cottrell Ballroom at UNG's ...
Azenosertib is positioned as a potentially first-in-class and best-in-class WEE1 inhibitor ... that an abstract has been accepted for poster presentation at the 2025 American Society of Clinical ...
SAN DIEGO, April 23, 2025 (GLOBE NEWSWIRE) -- Zentalis ® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class ...
Enliven's discovery process combines deep insights in clinically validated biological targets and differentiated chemistry to design potentially first-in-class or best-in-class therapies.
Abstract and poster presentation details are below ... developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1+ platinum-resistant ...
The poster will include clinical data as of an April 4, 2025 data cutoff from the Company's ongoing Phase 1/2 clinical trial evaluating azenosertib in combination with encorafenib and cetuximab in ...